AluY-mediated germline deletion, duplication and somatic stem cell reversion inUBE2Tdefines a new subtype of Fanconi anemia
Authors:
Open Access
- 17 June 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 24 (18) , 5093-5108
Abstract
Fanconi anemia (FA) is a rare inherited disorder clinically characterized by congenital malformations, progressive bone marrow failure and cancer susceptibility. At the cellular level, FA is associated with hypersensitivity to DNA-crosslinking genotoxins. Eight of 17 known FA genes assemble the FA E3 ligase complex, which catalyzes monoubiquitination of FANCD2 and is essential for replicative DNA crosslink repair. Here, we identify the first FA patient with biallelic germline mutations in the ubiquitin E2 conjugase UBE2T. Both mutations were aluY-mediated: a paternal deletion and maternal duplication of exons 2–6. These loss-of-function mutations in UBE2T induced a cellular phenotype similar to biallelic defects in early FA genes with the absence of FANCD2 monoubiquitination. The maternal duplication produced a mutant mRNA that could encode a functional protein but was degraded by nonsense-mediated mRNA decay. In the patient's hematopoietic stem cells, the maternal allele with the duplication of exons 2–6 spontaneously reverted to a wild-type allele by monoallelic recombination at the duplicated aluY repeat, thereby preventing bone marrow failure. Analysis of germline DNA of 814 normal individuals and 850 breast cancer patients for deletion or duplication of UBE2T exons 2–6 identified the deletion in only two controls, suggesting aluY-mediated recombinations within the UBE2T locus are rare and not associated with an increased breast cancer risk. Finally, a loss-of-function germline mutation in UBE2T was detected in a high-risk breast cancer patient with wild-type BRCA1/2. Cumulatively, we identified UBE2T as a bona fide FA gene (FANCT) that also may be a rare cancer susceptibility gene.Keywords
Funding Information
- NIH (R01 CA155294-01)
- BMBF
- ‘Inherited bone marrow failure syndromes’
- the Scottish Institute for Cell Signalling by the Wellcome Trust strategic award (097945/B/11/Z)
- the Lilly Foundation Physician/Scientist initiative
- Indiana University is a Center for Excellence in Molecular Hematology (P30)
This publication has 75 references indexed in Scilit:
- Mutations in ERCC4, Encoding the DNA-Repair Endonuclease XPF, Cause Fanconi AnemiaThe American Journal of Human Genetics, 2013
- A Protein Prioritization Approach Tailored for the FA/BRCA PathwayPLOS ONE, 2013
- Fanconi anemia (FA) binding protein FAAP20 stabilizes FA complementation group A (FANCA) and participates in interstrand cross-link repairProceedings of the National Academy of Sciences, 2012
- DNA interstrand crosslink repair and cancerNature Reviews Cancer, 2011
- Correct mRNA Processing at a Mutant TT Splice Donor in FANCC Ameliorates the Clinical Phenotype in Patients and Is Enhanced by Delivery of Suppressor U1 snRNAsThe American Journal of Human Genetics, 2010
- Susceptibility Pathways in Fanconi's Anemia and Breast CancerNew England Journal of Medicine, 2010
- Nonhomologous DNA End Joining (NHEJ) and Chromosomal Translocations in Humans2009
- Inhibition of Nonsense-mediated mRNA Decay by the Natural Product Pateamine A through Eukaryotic Initiation Factor 4AIIIJournal of Biological Chemistry, 2009
- Fanconi anemia and its diagnosisMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2009
- Identification and characterization of mutations in FANCL gene: A second case of Fanconi anemia belonging to FA-L complementation groupHuman Mutation, 2009